Free Access
Vet. Res.
Volume 41, Number 3, May–June 2010
Number of page(s) 13
Published online 18 January 2010
How to cite this article Vet. Res. (2010) 41:31
  • Allan G.M., Ellis J.A., Porcine circoviruses: a review, J. Vet. Diagn. Invest. (2000) 12:3–14. [PubMed]
  • Allan G.M., Caprioli A., McNair I., Lagan-Tregaskis P., Ellis J., Krakowka S., , Porcine circovirus 2 replication in colostrum-deprived piglets following experimental infection and immune stimulation using a modified live vaccine against porcine respiratory and reproductive syndrome virus, Zoonoses Public Health (2007) 54:214–222. [CrossRef] [PubMed]
  • Bereiter M., Young T.F., Joo H.S., Ross R.F., Evaluation of the ELISA and comparison to the complement fixation test and radial immunodiffusion enzyme assay for detection of antibodies against Mycoplasma hyopneumoniae in swine serum, Vet. Microbiol. (1990) 25:177–192. [CrossRef] [PubMed]
  • Bolin S.R., Stoffregen W.C., Nayar G.P., Hamel A.L., Postweaning multisystemic wasting syndrome induced after experimental inoculation of cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus, J. Vet. Diagn. Invest. (2001) 13:185–194. [PubMed]
  • Brunborg I.M., Moldal T., Jonassen C.M., Quantitation of porcine circovirus type 2 isolated from serum/plasma and tissue samples of healthy pigs and pigs with postweaning multisystemic wasting syndrome using a TaqMan-based real-time PCR, J. Virol. Methods (2004) 122:171–178. [CrossRef] [PubMed]
  • Caprioli A., McNeilly F., McNair I., Lagan-Tregaskis P., Ellis J., Krakowka S., , PCR detection of porcine circovirus type 2 (PCV2) DNA in blood, tonsillar and faecal swabs from experimentally infected pigs, Res. Vet. Sci. (2006) 81:287–292. [CrossRef] [PubMed]
  • Cheung A.K., Lager K.M., Kohutyuk O.I., Vincent A.L., Henry S.C., Baker R.B., , Detection of two porcine circovirus type 2 genotypic groups in United States swine herds, Arch. Virol. (2007) 152:1035–1044. [CrossRef] [PubMed]
  • Cheung A.K., Homologous recombination within the capsid gene of porcine circovirus type 2 subgroup viruses via natural co-infection, Arch. Virol. (2009) 154:531–534. [CrossRef] [PubMed]
  • Dupont K., Nielsen E.O., Baekbo P., Larsen L.E., Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time, Vet. Microbiol. (2008) 128:56–64. [CrossRef] [PubMed]
  • Fachinger V., Bischoff R., Jedidia S.B., Saalmuller A., Elbers K., The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex, Vaccine (2008) 26:1488–1499. [PubMed]
  • Fenaux M., Halbur P.G., Gill M., Toth T.E., Meng X.J., Genetic characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning multisystemic wasting syndrome in different geographic regions of North America and development of a differential PCR-restriction fragment length polymorphism assay to detect and differentiate between infections with PCV-1 and PCV-2, J. Clin. Microbiol. (2000) 38:2494–2503. [PubMed]
  • Fenaux M., Halbur P.G., Haqshenas G., Royer R., Thomas P., Nawagitgul P., , Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions, J. Virol. (2002) 76:541–551. [CrossRef] [PubMed]
  • Fenaux M., Opriessnig T., Halbur P.G., Meng X.J., Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs, J. Virol. (2003) 77:11232–11243. [CrossRef] [PubMed]
  • Fenaux M., Opriessnig T., Halbur P.G., Xu Y., Potts B., Meng X.J., Detection and in vitro and in vivo characterization of porcine circovirus DNA from a porcine-derived commercial pepsin product, J. Gen. Virol. (2004) 85:3377–3382. [CrossRef] [PubMed]
  • Fort M., Olvera A., Sibila M., Segalés J., Mateu E., Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs, Vet. Microbiol. (2007) 125:244–255. [CrossRef] [PubMed]
  • Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segales J., Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins, Vaccine (2008) 26:1063–1071. [PubMed]
  • Harms P.A., Sorden S.D., Halbur P.G., Bolin S.R., Lager K.M., Morozov I., Paul P.S., Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus, Vet. Pathol. (2001) 38:528–539. [CrossRef] [PubMed]
  • Hesse R., Kerrigan M., Rowland R.R., Evidence for recombination between PCV2a and PCV2b in the field, Virus Res. (2008) 132:201–207. [CrossRef] [PubMed]
  • Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., , A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2, J. Am. Vet. Med. Assoc. (2008) 232:906–912. [CrossRef] [PubMed]
  • Jacobsen B., Krueger L., Seeliger F., Bruegmann M., Segales J., Baumgaertner W., Retrospective study on the occurrence of porcine circovirus 2 infection and associated entities in Northern Germany, Vet. Microbiol. (2009) 138:27–33. [CrossRef] [PubMed]
  • James F.C., McCulloch C.E., Multivariate-analysis in ecology and systematic – Panacea or Pandora box, Annu. Rev. Ecol. Syst. (1990) 21:129–166.
  • Kekarainen T., Montoya M., Mateu E., Segales J., Porcine circovirus type 2-induced interleukin-10 modulates recall antigen responses, J. Gen. Virol. (2008) 89:760–765. [CrossRef] [PubMed]
  • Kixmoller M., Ritzmann M., Eddicks M., Saalmuller A., Elbers K., Fachinger V., Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2, Vaccine (2008) 26:3443–3451. [CrossRef] [PubMed]
  • Larochelle R., Magar R., D’Allaire S., Comparative serologic and virologic study of commercial swine herds with and without postweaning multisystemic wasting syndrome, Can. J. Vet. Res. (2003) 67:114–120. [PubMed]
  • Madson D.M., Ramamoorthy S., Kuster C., Pal N., Meng X.J., Halbur P.G., Opriessnig T., Characterization of shedding patterns of porcine circovirus types 2a and 2b in experimentally inoculated mature boars, J. Vet. Diagn. Invest. (2008) 20:725–734. [PubMed]
  • Madson D.M., Patterson A.R., Ramamoorthy S., Pal N., Meng X.J., Opriessnig T., Reproductive failure experimentally induced in sows via artificial insemination with semen spiked with porcine circovirus type 2, Vet. Pathol. (2009) 46:707–716. [CrossRef] [PubMed]
  • Magar R., Müller P., Larochelle R., Retrospective serological survey of antibodies to porcine circovirus type 1 and type 2, Can. J. Vet. Res. (2000) 64:184–186. [PubMed]
  • Meerts P., Van Gucht S., Cox E., Vandebosch A., Nauwynck H.J., Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication, Viral. Immunol. (2005) 18:333–341. [CrossRef] [PubMed]
  • Meerts P., Misinzo G., Lefebvre D., Nielsen J., Bøtner A., Kristensen C.S., Nauwynck H.J., Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease, BMC Vet. Res. (2006) 30:6. [CrossRef]
  • Mengeling W.L., Ridpath J.F., Vorwald A.C., Size and antigenic comparisons among the structural proteins of selected autonomous parvoviruses, J. Gen. Virol. (1988) 69:825–837. [CrossRef] [PubMed]
  • Nawagitgul P., Harms P.A., Morozov I., Thacker B.J., Sorden S.D., Lekcharoensuk C., Paul P.S., Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV, Clin. Diagn. Lab. Immunol. (2002) 9:33–40. [CrossRef] [PubMed]
  • Opriessnig T., Yu S., Gallup J.M., Evans R.B., Fenaux M., Pallares F., , Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus, Vet. Pathol. (2003) 40:521–529. [CrossRef] [PubMed]
  • Opriessnig T., Thacker E.L., Yu S., Fenaux M., Meng X.J., Halbur P.G., Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2, Vet. Pathol. (2004) 41:624–640. [CrossRef] [PubMed]
  • Opriessnig T., McKeown N.E., Zhou E.M., Meng X.J., Halbur P.G., Genetic and experimental comparison of porcine circovirus type 2 (PCV2) isolates from cases with and without PCV2-associated lesions provides evidence for differences in virulence, J. Gen. Virol. (2006) 87:2923–2932. [CrossRef] [PubMed]
  • Opriessnig T., Fenaux M., Thomas P., Hoogland M.J., Rothschild M.F., Meng X.J., Halbur P.G., Evidence of breed-dependent differences in susceptibility to porcine circovirus type-2-associated disease and lesions, Vet. Pathol. (2006) 43:281–293. [CrossRef] [PubMed]
  • Opriessnig T., Meng X.J., Halbur P.G., Porcine circovirus Type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies, J. Vet. Diagn. Invest. (2007) 19:591–615. [PubMed]
  • Opriessnig T., Madson D.M., Prickett J.R., Kuhar D., Lunney J.K., Elsener J. , Halbur P.G., Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection, Vet. Microbiol. (2008) 131:103–114. [CrossRef] [PubMed]
  • Opriessnig T., Ramamoorthy S., Madson D.M., Patterson A.R., Pal N., Carman S., , Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection, J. Gen. Virol. (2008) 89:2482–2491. [CrossRef] [PubMed]
  • Opriessnig T., Patterson A.R., Elsener J., Meng X.J., Halbur P.G., Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2, Clin. Vaccine Immunol. (2008) 15:397–401. [CrossRef] [PubMed]
  • Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G., Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2–3-months post vaccination, Vaccine (2009) 27:1002–1007. [CrossRef] [PubMed]
  • Patterson A.R., Johnson J., Ramamoorthy S., Meng X.J., Halbur P.G., Opriessnig T., Comparison of three enzyme-linked immunosorbent assays to detect porcine circovirus-2 (PCV-2)-specific antibodies after vaccination or inoculation of pigs with distinct PCV-1 or PCV-2 isolates, J. Vet. Diagn. Invest. (2008) 20:744–751. [PubMed]
  • Pogranichnyy R.M., Yoon K.J., Harms P.A., Swenson S.L., Zimmerman J.J., Sorden S.D., Characterization of immune response of young pigs to porcine circovirus type 2 infection, Viral Immunol. (2000) 13:143–153. [CrossRef] [PubMed]
  • Shibata I., Okuda Y., Yazawa S., Ono M., Sasaki T., Itagaki M., , PCR detection of porcine circovirus type 2 DNA in whole blood, serum, oropharyngeal swab, nasal swab, and feces from experimentally infected pigs and field cases, J. Vet. Med. Sci. (2003) 65:405–408. [CrossRef] [PubMed]
  • Sorden S.D., Harms P.A., Nawagitgul P., Cavanaugh D., Paul P.S., Development of a polyclonal-antibody-based immunohistochemical method for the detection of type 2 porcine circovirus in formalin-fixed, paraffin-embedded tissue, J. Vet. Diagn. Invest. (1999) 11:528–530. [PubMed]
  • Tischer I., Gelderblom H., Vettermann W., Koch M.A., A very small porcine virus with circular single-stranded DNA, Nature (1982) 295:64–66. [CrossRef] [PubMed]
  • Wellenberg G.J., Stockhofe-Zurwieden N., De Jong M.F. , Boersma W.J., Elbers A.R., Excessive porcine circovirus type 2 antibody titres may trigger the development of porcine dermatitis and nephropathy syndrome: a case-control study, Vet. Microbiol. (2004) 99:203–214. [CrossRef] [PubMed]
  • Yu S., Opriessnig T., Kitikoon P., Nilubol D., Halbur P.G., Thacker E., Porcine circovirus type 2 (PCV2) distribution and replication in tissues and immune cells in early infected pigs, Vet. Immunol. Immunopathol. (2007) 115:261–272. [CrossRef] [PubMed]